"Maintaining a conceptual divide btw addictions and other psychiatric disorders reinforces diagnostic “tunnel vision,” constraining our understanding of neuropsychopathology and contributing to persistent gaps in care and treatment accessibility."
https://www.cambridge.org/core/journals/irish-journal-of-psychological-medicine/article/addiction-is-a-mental-disorder-within-the-mental-health-spectrum-and-it-matters/8EDA704DF6C14361147C87FB83EEABFD

#SubstanceUse

Researching #IntegratedCare, especially for people w #multimorbidity, shows that silos do not start at the psychological vs. physiological, but already within those categories.

#MentalIllness #HealthServices

Addiction is a mental disorder within the mental health spectrum, and it matters | Irish Journal of Psychological Medicine | Cambridge Core

Addiction is a mental disorder within the mental health spectrum, and it matters

Cambridge Core

Summarising literature from 25yrs, the paper shows that most studies investigating cost in global #NCD research emphasise tangible costs (direct & indirect expenses), while largely neglecting intangible costs:
https://link.springer.com/article/10.1186/s12982-025-00964-1

Glad to see our recent study included and summarised 👇
https://gh.bmj.com/content/9/1/e013606

#GlobalHealth #GlobalMentalHealth #Multimorbidity #LTC

A #ScopingReview of quality of life measures in treatment for substance misuse:
https://link.springer.com/article/10.1007/s11136-025-04072-0

Urgent development topics:
Culturally adapted measures, how intersecting identities shape QoL experience, impacts of stigma on QoL, and the roles of socioeconomic factors and cooccurring conditions.
#SDH #Multimorbidity

#HRQOL

Quality of life measures in treatment for active substance misuse: a scoping review - Quality of Life Research

Purpose Unlike previous reviews on quality of life (QoL) and substance use disorders (SUD), this scoping review focuses on QoL within the context of SUD treatment and active substance misuse. This review delineates and describes QoL measures, assesses their application, and explores the influence of demographics on QoL outcomes. Methods Five databases were searched (EMBASE, Web of Science, PsycINFO, PubMed, and Scopus) using keywords related to QoL, clinician-verified SUD, and SUD treatment. All studies were published in English before June 1st, 2025. Two reviewers screened abstracts and full text for eligibility and study elements. The first author extracted data regarding methodology, substance use, treatment, and QoL measures. The PRISMA-ScR checklist guided this study and the reporting process for rigor and transparency. Results Of the 11,078 initially identified articles, 108 were extracted for analysis. QoL measures accounted for multiple domains (e.g., physical, psychological, social, environmental, independence, security, and spiritual). Studies included male and female participants, all over the age of 18. Results found that many studies under-reported race, ethnicity, and cultural contexts, as well as high variability in the definition of QoL domains and standardization across treatment locations and geographic regions. Studies from Asia primarily showed preference for the WHOQOL-BREF measure compared to North America and Europe, which showed varied preference for measures. The most common QoL domains assessed were psychological, physical, and social. Conclusion This review highlights the need to operationalize QoL domains and assessment approaches in SUD treatment research to facilitate meaningful comparisons and enhance our understanding of treatment effectiveness.

SpringerLink

A workshop of the MLTC Cross- #NIHR Collaboration programme suggests three challenge themes in #multimorbidity research #methodology:
https://journals.sagepub.com/doi/full/10.1177/26335565251372222

Wired:
Transparency, standardisation, reproducibility of multimorbidity research made the list!

Tired:
Bullet points in figure 1 have more detail on building methodological capacity than the text. Investing in methodologists (of any kind) is not part mentioned as far as I can see.

#Training #ECRs #Epidemiology #Statistics

Addressing methodological challenges in multiple long-term conditions research: A stakeholder workshop using a nominal group technique method - Hajira Dambha-Miller, Glenn Simpson, Lucy Smith, James Finney, Salwa S. Zghebi, Sarah E. Hughes, Victoria L. Keevil, Ge Yu, Clare MacRae, Kamlesh Khunti, Colin McCowan, 2025

Background Multiple long-term conditions (MLTC) - which refer to the coexistence in an individual of two or more long-term conditions - are a growing global con...

Sage Journals

Người Việt từ 64 tuổi trở lên thường mắc nhiều bệnh tật cùng lúc, khiến 10 năm cuối đời không khỏe mạnh như ở các nước khác. Dù sống thọ, sức khỏe vẫn cần được chú ý hơn để cải thiện chất lượng cuộc sống!

#SứcKhỏe #Health #NgườiViệt #TuổiGià #Aging #Multimorbidity

https://vietnamnet.vn/nguoi-viet-tren-64-tuoi-mac-cung-luc-nhieu-benh-tat-2443988.html

Người Việt trên 64 tuổi mắc cùng lúc nhiều bệnh tật

Người Việt Nam từ 64 tuổi trở lên mắc cùng lúc nhiều bệnh tật, cho thấy dù sống thọ nhưng 10 năm cuối đời không khỏe mạnh như người dân các nước.

Vietnamnet.vn

Meta-analysis of #TaskShifting / #TaskSharing for managing #Multimorbidity shows some associations w depression (d=-.27, k=14), quality of life (d=.10, k=12), increased anxiety (d=.14, k=5), mortality (OR=.77, k=4).

https://fmch.bmj.com/content/13/3/e003390

#GlobalHealth #GlobalMentalHealth #HRQL #HRQoL

Global evidence on the effectiveness of task-shifting and task-sharing strategies for managing individuals with multimorbidity: systematic review and meta-analysis

Introduction Task-shifting and task-sharing strategies show promise for managing chronic diseases especially in low-income and middle-income countries (LMICs), though their effectiveness in multimorbidity management remains unclear. This study synthesised evidence on task-shifting and task-sharing strategies globally and assessed the impact on core health outcomes in multimorbidity management.Methods We conducted a systematic review and meta-analysis of global studies evaluating task-shifting and sharing interventions for individuals with multimorbidity. Six databases, including PubMed, Embase, Web of Science, Ovid (Medline), CINAHL and Cochrane Library, were searched for studies reporting the core outcomes of multimorbidity management in quality of life, mortality, hospitalisation, emergency department visits and symptoms of depression and anxiety. Random-effects models were used to calculate pooled effect sizes with heterogeneity assessed through subgroup and meta-regression analyses.Results From 8471 records, 36 studies from 14 countries were included, with only 5 conducted in LMICs. Twenty-one studies, encompassing 20 989 participants, were eligible for meta-analysis. More than half of the studies involved nurses as delegates, with some sharing the tasks with health professionals and about 10% of studies involved non-health professionals, including community healthcare workers as delegates to share the responsibility in caring for individuals with multimorbidity. Most studies were multicomponent, with 16.7% addressing all guideline-recommended aspects of multimorbidity management. By pooling the findings, task-shifting and task-sharing interventions were associated with a 27% reduction in mortality (OR: 0.73, 95% CI: 0.55 to 0.97, I²=0%), a modest improvement in quality of life (standardised mean difference (SMD): 0.1, 95% CI: 0.03 to 0.17, I²=47%) and reduced symptoms of depression (SMD: 0.27, 95% CI: −0.52 to –0.02, I²=90%), but showed no significant effect on hospitalisation, emergency visits or anxiety-related symptoms.Conclusions Some evidence, although limited in existing research, indicates the great potential of task-shifting and task-sharing strategies in supporting management of multimorbidity. Further research is needed to optimise and adopt these interventions, particularly in LMICs where evidence remains scarce.PROSPERO registration number CRD42024526845.

Family Medicine and Community Health

An analysis of electronic health records shows that a third of patients with SMI [severe #MentalIllness] in UK #PrimaryCare are excepted from #MentalHealth indicators at least once. Given the persisting health inequalities in people with #SMI this is concerning:
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/characteristics-of-people-with-severe-mental-illness-excluded-from-incentivised-physical-health-checks-in-the-uk-electronic-healthcare-record-study/806549AACA75DB0BFA98521A761C36AF

#Multimorbidity

Characteristics of people with severe mental illness excluded from incentivised physical health checks in the UK: electronic healthcare record study | The British Journal of Psychiatry | Cambridge Core

Characteristics of people with severe mental illness excluded from incentivised physical health checks in the UK: electronic healthcare record study

Cambridge Core

'Multimorbidity Patterns in Patients with Pulmonary Arterial Hypertension Identified Through Hospital Discharge Records: A Network-Based Analysis' - an article in Cardiovascular Innovations and Applications on #ScienceOpen:

🔗 https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0008

🖇️ #CardiovascularMedicine #CardiologyResearch #Multimorbidity #NetworkMedicine

Multimorbidity Patterns in Patients with Pulmonary Arterial Hypertension Identified Through Hospital Discharge Records: A Network-Based Analysis

<div xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="section"> <a class="named-anchor" id="d7816681e172"> <!-- named anchor --> </a> <h5 class="section-title" id="d7816681e173">Background:</h5> <p dir="auto" id="d7816681e175">Considerable variability exists in the clinical presentations of pulmonary arterial hypertension (PAH). Greater understanding of the comorbidities observed in Chinese patients with PAH is urgently needed. </p> </div><div xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="section"> <a class="named-anchor" id="d7816681e177"> <!-- named anchor --> </a> <h5 class="section-title" id="d7816681e178">Methods:</h5> <p dir="auto" id="d7816681e180">This 10-year retrospective analysis was based on clinical data from hospital discharge records for individuals diagnosed with PAH (n = 2584). We used propensity score matching to match patients with PAH to individuals without a PAH diagnosis in a ratio of 1:1, by age, sex, discharge time, and department, over the same period. We constructed multimorbidity networks based on sex and age, and used the cosine index to measure the co-occurrence of chronic diseases. </p> </div><div xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="section"> <a class="named-anchor" id="d7816681e182"> <!-- named anchor --> </a> <h5 class="section-title" id="d7816681e183">Results:</h5> <p dir="auto" id="d7816681e185">The mean numbers of comorbidities were 4.7 and 3.8 for patients with PAH and controls, respectively. The main central and hub disorders were renal osteodystrophy, cardiovascular illnesses, background retinopathy, diabetes mellitus, systemic lupus erythematosus, epilepsy, and autoimmune hemolytic anemia. The average neighbor degree and closeness were significantly smaller in the multimorbidity networks of patients with PAH than control participants (Kolmogorov–Smirnov test, all P < 0.05). </p> </div><div xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="section"> <a class="named-anchor" id="d7816681e187"> <!-- named anchor --> </a> <h5 class="section-title" id="d7816681e188">Conclusion:</h5> <p dir="auto" id="d7816681e190">Our findings may aid in preventing comorbidities among patients with PAH and deepening understanding of the underlying physiopathological mechanisms. </p> </div>

ScienceOpen

Telehealth interventions for managing #multimorbidity can be cost-effective and improve access and health outcomes in rural and remote areas. This #ScopingReview (n=15) stresses variability in findings and need for standardised implementation:
https://journals.sagepub.com/doi/full/10.1177/26335565251344433

#ImplementationScience

This study used data from national registers to examine the prevalence of multimorbidity in the Danish population btw 2000-2018. They found that the prevalence of #multimorbidity doubled during the study period, with a stronger increase in older age groups:
https://journals.sagepub.com/doi/full/10.1177/26335565251331182
For example, the number of people with at least one morbidity was 26.2% in 2000 and 41.9% in 2018; and the prevalence of multimorbidity (disease count) increased from 7.1% to 16.1%.